Court Advises in Favor of Viora ; Syneron Withdraws its Request for a Temporary Injunction against Viora

Online, August 6, 2010 (Newswire.com) - Viora, a leading global medical aesthetics company, announces that the Central District Court in Israel advised Syneron Medical LTD (NASDAQ: ELOS) to withdraw its request for relief in the form of a temporary injunction against the Reaction™ by Viora. Following a discussion on August 1st 2010, the court approved Syneron's withdrawal of the request.

Syneron's lawsuit, signed by its chairman Dr. Shimon Eckhouse, acknowledges that the Reaction™ (multifrequency RF CORE™ technology patented by Viora) is equipped with the future RF technology for medical aesthetic applications.

"We are extremely pleased with Syneron's decision to follow the court's advice" said Mr. Josef Luzon, CEO of Viora Inc. "Viora will continue to communicate to the market and to each customer the superiority of its multifrequency RF device, the Reaction™, powered by its proprietary and patented CORE™ technology".

"Viora regrets that Syneron has chosen to file a petty, unfounded and baseless suit, after failing to compete with Viora's superior multifrequency technology of the Reaction™ in the market. Syneron demonstrates legal hooliganism by using the lawsuit to cast aspersions on Viora's product. Viora will continue to compete strongly in the marketplace by supplying doctors with its high quality devices and will continue to defend itself vigorously against Syneron's lawsuit." Said Mr. Danny Erez, CEO Viora LTD.

About the Reaction™
The Reaction™ (http://www.vioramed.com) is the first and only FDA cleared bipolar RF device with multi frequency and vacuum therapy for body contouring, offering the medical professional an unheard of level of control and precision to target specific depths, a combination that delivers immediately visible results.

The availability of different frequencies optimizes the thermal effect at different tissue depths and improves treatment accuracy and offers flexibility by providing 144 treatments combinations for the practitioner.

In addition, due to its unique technology, Reaction™'s treatments are comfortable for the patient. The Reaction™'s unique design of its applicators makes the treatment smooth and relaxing for the patient. Light and easy to operate, the Reaction™'s non labor intensive applicators enable the practitioner to schedule treatments one after the other as well as ensure better treatment results.

In clinical tests, patients who underwent a skin tightening treatment course demonstrated an 81 percent improvement in wrinkles and skin laxity. A similar study evaluated the performance of CORE™ technology for cellulite reduction where patients showed a 55 percent improvement in the appearance of cellulite.

The Reaction™ has been selling globally for over a year and recently received FDA clearance and Health Canada certification, and is now available for sale in North America as well.